Concepts (118)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Authorship | 4 | 2022 | 281 | 2.240 |
Why?
|
| Electroconvulsive Therapy | 4 | 2023 | 500 | 1.850 |
Why?
|
| Bibliometrics | 3 | 2021 | 351 | 1.550 |
Why?
|
| Periodicals as Topic | 3 | 2022 | 1469 | 0.990 |
Why?
|
| Journal Impact Factor | 2 | 2022 | 156 | 0.880 |
Why?
|
| Publishing | 2 | 2021 | 837 | 0.830 |
Why?
|
| Hospitals, General | 2 | 2021 | 795 | 0.650 |
Why?
|
| Depressive Disorder, Major | 5 | 2024 | 4732 | 0.570 |
Why?
|
| Psychotic Disorders | 4 | 2023 | 3170 | 0.570 |
Why?
|
| Consumer Health Information | 1 | 2019 | 209 | 0.560 |
Why?
|
| Physicians, Women | 1 | 2022 | 491 | 0.520 |
Why?
|
| Natural Language Processing | 4 | 2020 | 1128 | 0.500 |
Why?
|
| Psychotropic Drugs | 1 | 2019 | 882 | 0.450 |
Why?
|
| Conflict of Interest | 1 | 2018 | 549 | 0.450 |
Why?
|
| Risk-Taking | 1 | 2019 | 999 | 0.430 |
Why?
|
| Delirium | 5 | 2021 | 1653 | 0.360 |
Why?
|
| Psychiatry | 2 | 2019 | 1683 | 0.340 |
Why?
|
| Biomedical Research | 2 | 2023 | 3416 | 0.340 |
Why?
|
| Dermatology | 1 | 2018 | 912 | 0.310 |
Why?
|
| Psychopathology | 3 | 2021 | 426 | 0.300 |
Why?
|
| Internet | 1 | 2019 | 3073 | 0.280 |
Why?
|
| Societies, Medical | 1 | 2018 | 3890 | 0.270 |
Why?
|
| Bipolar Disorder | 2 | 2022 | 5076 | 0.250 |
Why?
|
| Mental Disorders | 2 | 2021 | 6788 | 0.220 |
Why?
|
| Antipsychotic Agents | 3 | 2021 | 3060 | 0.210 |
Why?
|
| Self Report | 3 | 2023 | 3699 | 0.210 |
Why?
|
| Schizophrenia | 4 | 2023 | 6914 | 0.200 |
Why?
|
| Hospitals, Psychiatric | 1 | 2023 | 321 | 0.200 |
Why?
|
| Practice Guidelines as Topic | 1 | 2018 | 7460 | 0.190 |
Why?
|
| Treatment Outcome | 5 | 2024 | 64879 | 0.190 |
Why?
|
| Electronic Health Records | 7 | 2024 | 4737 | 0.180 |
Why?
|
| Antidepressive Agents | 2 | 2024 | 2888 | 0.170 |
Why?
|
| Antimetabolites | 1 | 2020 | 127 | 0.170 |
Why?
|
| Cycloserine | 1 | 2020 | 118 | 0.170 |
Why?
|
| Psychomotor Agitation | 1 | 2020 | 306 | 0.150 |
Why?
|
| Delusions | 1 | 2020 | 298 | 0.150 |
Why?
|
| Demography | 1 | 2023 | 1648 | 0.150 |
Why?
|
| Receptors, Formyl Peptide | 1 | 2018 | 146 | 0.150 |
Why?
|
| Hospital Departments | 1 | 2017 | 136 | 0.140 |
Why?
|
| Retrospective Studies | 8 | 2023 | 80121 | 0.140 |
Why?
|
| Humans | 30 | 2024 | 759255 | 0.130 |
Why?
|
| Antimanic Agents | 1 | 2019 | 520 | 0.130 |
Why?
|
| Hippocampus | 3 | 2023 | 3727 | 0.120 |
Why?
|
| Genome-Wide Association Study | 3 | 2018 | 12580 | 0.120 |
Why?
|
| Histone Deacetylases | 1 | 2018 | 718 | 0.120 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2018 | 1173 | 0.110 |
Why?
|
| Editorial Policies | 1 | 2018 | 457 | 0.110 |
Why?
|
| Hospitalization | 5 | 2021 | 10734 | 0.110 |
Why?
|
| Interleukins | 1 | 2018 | 780 | 0.110 |
Why?
|
| Medicine | 1 | 2021 | 943 | 0.100 |
Why?
|
| Arousal | 1 | 2018 | 1157 | 0.100 |
Why?
|
| Reward | 1 | 2019 | 954 | 0.100 |
Why?
|
| Biological Specimen Banks | 1 | 2017 | 777 | 0.100 |
Why?
|
| Databases, Genetic | 1 | 2018 | 1740 | 0.090 |
Why?
|
| Cognition | 2 | 2019 | 6940 | 0.090 |
Why?
|
| Logistic Models | 2 | 2023 | 13309 | 0.090 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2020 | 2282 | 0.090 |
Why?
|
| Female | 14 | 2024 | 390240 | 0.080 |
Why?
|
| Cohort Studies | 6 | 2023 | 41247 | 0.080 |
Why?
|
| Patient Admission | 1 | 2017 | 1383 | 0.080 |
Why?
|
| Psychotherapy | 1 | 2018 | 1638 | 0.080 |
Why?
|
| Neuropsychological Tests | 2 | 2019 | 7003 | 0.080 |
Why?
|
| Genetic Loci | 1 | 2018 | 2617 | 0.080 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2018 | 1889 | 0.080 |
Why?
|
| Prefrontal Cortex | 1 | 2018 | 2210 | 0.080 |
Why?
|
| Sex Factors | 1 | 2022 | 10518 | 0.070 |
Why?
|
| Medication Adherence | 1 | 2019 | 2161 | 0.070 |
Why?
|
| Male | 12 | 2024 | 358719 | 0.070 |
Why?
|
| Pregnancy Outcome | 1 | 2018 | 2901 | 0.070 |
Why?
|
| Academic Medical Centers | 1 | 2017 | 2750 | 0.070 |
Why?
|
| Adult | 10 | 2024 | 219390 | 0.070 |
Why?
|
| Genetic Variation | 2 | 2018 | 6531 | 0.060 |
Why?
|
| Anxiety | 1 | 2020 | 4527 | 0.060 |
Why?
|
| Phenotype | 2 | 2021 | 16532 | 0.060 |
Why?
|
| Middle Aged | 9 | 2024 | 219653 | 0.060 |
Why?
|
| Carrier Proteins | 1 | 2018 | 4939 | 0.060 |
Why?
|
| Pregnancy Complications | 1 | 2018 | 2940 | 0.060 |
Why?
|
| Analgesics, Opioid | 1 | 2020 | 3759 | 0.060 |
Why?
|
| Positron-Emission Tomography | 1 | 2018 | 6436 | 0.050 |
Why?
|
| Prognosis | 1 | 2023 | 29561 | 0.050 |
Why?
|
| Brief Psychiatric Rating Scale | 1 | 2021 | 109 | 0.050 |
Why?
|
| Time Factors | 1 | 2023 | 40109 | 0.050 |
Why?
|
| Cholinergic Antagonists | 1 | 2021 | 164 | 0.040 |
Why?
|
| Psychiatric Status Rating Scales | 2 | 2022 | 6016 | 0.040 |
Why?
|
| Peer Review, Research | 1 | 2023 | 341 | 0.040 |
Why?
|
| Prescriptions | 1 | 2021 | 388 | 0.040 |
Why?
|
| Citalopram | 1 | 2021 | 402 | 0.040 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2018 | 17750 | 0.030 |
Why?
|
| Atrophy | 1 | 2021 | 1625 | 0.030 |
Why?
|
| Morphine | 1 | 2020 | 656 | 0.030 |
Why?
|
| Osteotomy | 1 | 2020 | 834 | 0.030 |
Why?
|
| New England | 1 | 2017 | 1042 | 0.030 |
Why?
|
| Genotype | 2 | 2018 | 12940 | 0.030 |
Why?
|
| Hemodynamics | 1 | 2023 | 4164 | 0.030 |
Why?
|
| United States | 1 | 2021 | 72237 | 0.030 |
Why?
|
| Disease | 1 | 2017 | 671 | 0.020 |
Why?
|
| Depression | 2 | 2022 | 8026 | 0.020 |
Why?
|
| Massachusetts | 1 | 2024 | 8788 | 0.020 |
Why?
|
| Suicidal Ideation | 1 | 2021 | 1429 | 0.020 |
Why?
|
| Case-Control Studies | 2 | 2018 | 21988 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 2021 | 3106 | 0.020 |
Why?
|
| Young Adult | 3 | 2021 | 58483 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2020 | 8549 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2024 | 14442 | 0.020 |
Why?
|
| Adolescent | 3 | 2021 | 87560 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2020 | 12386 | 0.020 |
Why?
|
| Risk | 1 | 2018 | 9623 | 0.020 |
Why?
|
| Aged | 4 | 2021 | 168617 | 0.020 |
Why?
|
| Models, Theoretical | 1 | 2017 | 3556 | 0.020 |
Why?
|
| Length of Stay | 1 | 2016 | 6452 | 0.010 |
Why?
|
| Pandemics | 1 | 2023 | 8609 | 0.010 |
Why?
|
| Aged, 80 and over | 2 | 2018 | 58867 | 0.010 |
Why?
|
| Inflammation | 1 | 2021 | 10747 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2018 | 26109 | 0.010 |
Why?
|
| Pregnancy | 1 | 2018 | 29658 | 0.010 |
Why?
|
| Infant | 1 | 2018 | 35941 | 0.010 |
Why?
|
| Risk Factors | 1 | 2021 | 74167 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2021 | 36160 | 0.010 |
Why?
|
Concepts
(118)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(31)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_